Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an Additional Director, designated him as Managing Director & ...

Furthermore, Biocon has scheduled a board meeting on April 4 to discuss and approve fundraising for its commercial business ...

Bains described FY25 as a year of consolidation for the biosimilars business. And with the expansion of Biocon's vertically integrated model into new geographies, he also anticipates the drugmaker ...

Peter Bains, CEO Designate, Syngene International Ltd said, "The Indian CRDMO sector is positioned for major transformation, with the potential to become a leader in serving the global biopharma ...

Current President & CEO Peter Bains will step down on 31 December 2018. He will also resign as a director of the Company simultaneously. Tamura, currently executive chairman, will become chairman ...

Syngene's CEO-designate Peter Bains said the "friction and delay" could be compressed, highlighting it was "a disadvantage that India has against other jurisdictions". India's health and finance ...

Syngene International appoints Peter Bains as MD & CEO. Syngene International announced that its board approved the appointment of Peter Bains as managing director (MD) and chief executive officer, ...